Attached files
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Amendment No. 4 to Registration Statement on Form S-1 of our report dated April 13, 2012, except as to the last paragraph in Note 16, as to which the date is July 12, 2012 relating to the consolidated financial statements of Hyperion Therapeutics, Inc., which appears in such Registration Statement. We also consent to the reference to us under the heading Experts in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
San Jose, California
July 13, 2012